Reporting quality of economic evaluations of the negotiated Traditional Chinese Medicines in national reimbursement drug list of China: A systematic review

被引：1

作者：

Yan, Juntao ^{[1
,2
]}

Bao, Shiyi ^{[1
,2
]}

Liu, Liu ^{[1
,2
]}

Zhang, Yu-Qing ^{[3
,4
,5
,6
]}

Ming, Jian ^{[1
,2
,7
]}

Wei, Yan ^{[1
,2
]}

Chen, Yingyao ^{[1
,2
]}

机构：

[1] Fudan Univ, Sch Publ Hlth, 138Yi Xue Yuan Rd, Shanghai 200032, Peoples R China

[2] Fudan Univ, Natl Hlth Commiss Key Lab Hlth Technol Assessment, Shanghai, Peoples R China

[3] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada

[4] Guanganmen Hosp, China Acad Chinese Med Sci, CEBIM Ctr Evidence Based Integrat Med Clar Collabo, Beijing, Peoples R China

[5] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China

[6] Univ Nottingham Ningbo, Nottingham Ningbo GRADE Ctr, Ningbo, Peoples R China

[7] IQVIA Solut Enterprise Management Consulting Shang, Shanghai, Peoples R China

来源：

INTEGRATIVE MEDICINE RESEARCH | 2023年 / 12卷 / 01期

关键词：

Economic evaluation; Traditional Chinese medicine; Appraisal of reporting qualit; CHEERS;

D O I：

10.1016/j.imr.2022.100915

中图分类号：

R [医药、卫生];

学科分类号：

10 ;

摘要：

Background: Traditional Medicine (TM) has a wide uptake in most countries. In China, Traditional Chinese Medicine (TCM) is a common kind of primary health because of its beneficial effects. This review aimed to appraise the publication reporting quality of economic evaluations for selective TCM in the National Reimbursement Drug List (NRDL), Version 2020, based on the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Methods: Electronic databases were searched for economic evaluation that supported the TCM negotia-tions in NRDL (2020 version) published from 2001 to 2021, including PubMed, Web of Science, Embase, CNKI, WanFang, and SinoMed. The CHEERS statement was used to appraise the reporting quality of in-cluded TCM economic evaluations.Results: A total of 360 articles were retrieved, but only 38 economic evaluations met the inclusion crite-ria. None of the articles reported all items in the CHEERS checklist. The mean score of included articles is low at 10.93 +/- 2.62, with an average scoring rate of 51.31 +/- 10.53%. The least reported items included: "Characterizing heterogeneity," "Conflicts of interest", "Discount rate," and "Study perspective," with a re-porting rate of 0.00%, 5.26%, 7.89%, and 15.79%, respectively. Conclusion: An upward trend occurred in the quantity and quality of the economic evaluation publica-tions of TCM in China. TCM economic evaluations are still at an early stage, with an urgent need for improving reporting quality. It may result from research experiences or different ideas between TCM and Western Medicine. Adhering to reporting guidelines like CHEERS and educating economic evaluation in-vestigators can improve TCM economic evaluations' reporting quality.(c) 2023 Korea Institute of Oriental Medicine. Published by Elsevier B.V.This is an open access article under the CC BY-NC-ND license( http://creativecommons.org/licenses/by-nc-nd/4.0/ )

引用

页数：10

共 69 条

[11]

Drummond MF., 1987, Methods for the economic evaluation of health care programmes.

[12] The cost-effectiveness of exercise-based cardiac rehabilitation: a systematic review of the characteristics and methodological quality of published literature [J].

Edwards, Katherine ;

Jones, Natasha ;

Newton, Julia ;

Foster, Charlie ;

Judge, Andrew ;

Jackson, Kate ;

Arden, Nigel K. ;

Pinedo-Villanueva, Rafael .

HEALTH ECONOMICS REVIEW, 2017, 7

[13] Quality of economic evaluations of drug-coated balloons and drug-eluting stents in peripheral artery disease: a systematic review [J].

Etangsale, Aurelie ;

Nunno, Leonarda ;

Pineau, Judith ;

Prognon, Patrice ;

Martelli, Nicolas .

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)

[14] CHEERS Reporting Guidelines for Economic Evaluations [J].

Fayanju, Oluwadamilola M. ;

Haukoos, Jason S. ;

Tseng, Jennifer F. .

JAMA SURGERY, 2021, 156 (07) :677-678

[15] Developing Traditional Chinese Medicine in the Era of Evidence-Based Medicine: Current Evidences and Challenges [J].

Fung, Foon Yin ;

Linn, Yeh Ching .

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015

[16]

Fuwen Y, 2012, TIANJIN PHARM, V24, P53

[17]

Guoen L, CHINA GUIDELINES PHA

[18]

Haiping W., 2016, TIANJIN PHARM, V28, P11

[19] Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations [J].

Herman, Patricia M. ;

Poindexter, Beth L. ;

Witt, Claudia M. ;

Eisenberg, David M. .

BMJ OPEN, 2012, 2 (05)

[20] Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review [J].

Hong, Dongzhe ;

Si, Lei ;

Jiang, Minghuan ;

Shao, Hui ;

Ming, Wai-kit ;

Zhao, Yingnan ;

Li, Yan ;

Shi, Lizheng .

PHARMACOECONOMICS, 2019, 37 (06) :777-818

← 1 2 3 4 5 6 7 →